The Knowledge and Evaluation Research Unit, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
J Clin Endocrinol Metab. 2012 Jan;97(1):49-58. doi: 10.1210/jc.2011-2100. Epub 2011 Nov 16.
The effect of intensive therapy to achieve tight glycemic control in patients hospitalized in non-critical care settings is unclear.
We conducted a systematic review and meta-analysis to determine the effect of intensive glycemic control strategies on the outcomes of death, stroke, myocardial infarction, incidence of infection, and hypoglycemia. We included randomized and observational studies. Bibliographic databases were searched through February 2010. Random effects model was used to pool results across studies.
Nineteen studies (nine randomized and 10 observational studies) were included. The risk of bias across studies was moderate. Meta-analysis demonstrates that intensive glycemic control was not associated with significant effect on the risk of death, myocardial infarction, or stroke. There was a trend for increased risk of hypoglycemia (relative risk, 1.58; 95% confidence interval, 0.97-2.57), particularly in surgical studies and when the planned glycemic target was achieved. Intensive glycemic control was associated with decreased risk of infection (relative risk, 0.41; 95% confidence interval, 0.21-0.77) that was mainly derived from studies in surgical settings.
Intensive control of hyperglycemia in patients hospitalized in non-critical care settings may reduce the risk of infection. The quality of evidence is low and mainly driven by studies in surgical settings.
在非重症监护病房住院的患者中,强化治疗以实现严格血糖控制的效果尚不清楚。
我们进行了系统评价和荟萃分析,以确定强化血糖控制策略对死亡、中风、心肌梗死、感染发生率和低血糖的影响。我们纳入了随机和观察性研究。通过 2010 年 2 月对文献数据库进行了搜索。使用随机效应模型对研究结果进行了汇总。
纳入了 19 项研究(9 项随机研究和 10 项观察性研究)。研究间的偏倚风险为中度。荟萃分析表明,强化血糖控制与死亡、心肌梗死或中风风险的显著降低无关。低血糖风险呈增加趋势(相对风险,1.58;95%置信区间,0.97-2.57),特别是在外科研究和计划血糖目标实现时。强化血糖控制与感染风险降低相关(相对风险,0.41;95%置信区间,0.21-0.77),这主要来源于外科环境下的研究。
在非重症监护病房住院的患者中强化控制高血糖可能会降低感染风险。证据质量较低,主要来源于外科环境下的研究。